| Financial Year |
March 31 2023 |
| Monetary Funds |
328,211,201.21 |
| Held-for-trading Financial Assets |
248,374,985.23 |
| Notes Receivable |
1,662,500.00 |
| Accounts Receivable |
182,283,506.31 |
| Advances to Suppliers |
4,924,345.95 |
| Other Receivables |
13,850,337.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
24,491,405.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
557,888,650.55 |
| Total Current Assets |
1,430,441,137.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,058,790.84 |
| Investment Properties |
-- |
| Fixed Assetes |
42,185,356.32 |
| Under-construction Projects |
12,832,649.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
896,079.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
395,564.88 |
| Deferred Income Tax Assets |
7,224,762.19 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
94,623,591.22 |
| Total Assets |
1,525,064,728.52 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
103,325,479.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,870,902.74 |
| Taxes Payable |
4,254,687.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,534,704.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,250,631.35 |
| Other Current Liabilities |
8,489,917.89 |
| Sub-Total of Current Liabilities |
267,674,054.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
699,126.29 |
| Total Liabilities |
268,373,181.24 |
| Paid-In Capital(Or Share Stock) |
155,040,000.00 |
| Capital Surplus |
681,208,556.69 |
| Surplus Reserve |
45,352,403.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
339,502,240.33 |
| Minority Stockholder's Interest |
35,588,346.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,221,103,200.72 |
| Owner's Equity（Stockholder's Equity） |
1,256,691,547.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,525,064,728.52 |
